NCT01840280View on ClinicalTrials.gov

A Non Interventional Study With Irinotecan Onkovis (Irinotecan) Utilized for the Treatment of Cancer

CompletedOBSERVATIONAL
Enrollment

324

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions
Carcinoma
Trial Locations (5)

01920

Practice, Elstra

04179

Practice, Leipzig

04683

Practice, Naunhof

01844

Practice, Neustadt/Sachsen

08412

Practice, Werdau

All Listed Sponsors
collaborator

AKP Freiburg GmbH

INDUSTRY

lead

Onkovis GmbH

INDUSTRY

NCT01840280 - A Non Interventional Study With Irinotecan Onkovis (Irinotecan) Utilized for the Treatment of Cancer | Biotech Hunter | Biotech Hunter